NASDAQ:ERNA 29 October 2025

Ernexa Therapeutics (ERNA) Skyrockets on Cancer Therapy Deal – Will Rally Last?

Ernexa Therapeutics shares jumped nearly 50% to $1.80 intraday on October 29, 2025, after announcing a manufacturing partnership with Cellipont Bioservices to advance its ovarian cancer cell therapy, ERNA-101, toward clinical trials. Trading volume surged. Despite the rally, ERNA stock remains down about 58% in 2025 and 89% year-on-year after previous setbacks and a reverse stock split.

29 October 2025

NASDAQ:ERNA·Pharmaceuticals·Stock Market

Blue Owl Capital Shares Drop 1.61% After Capping Fund Redemptions
April 2, 2026, 7:07 PM EDT. Blue Owl Capital (OWL) fell 1.61% to $8.57 on heavy volume as it announced a 5% redemption cap on two funds amid elevated withdrawal requests. The move aligns with similar restrictions by peers Apollo Global Management and Ares Management. Blue Owl, an alternative asset manager, faces investor concerns over private credit risk, worsened by geopolitical tensions and AI disruption fears in portfolio companies. The S&P 500 edged up 0.11%, Nasdaq gained 0.18%, while Blackstone and KKR shares declined. This development highlights ongoing challenges in the private credit sector, potentially impacting the broader financial market.